Literature DB >> 11465954

The number and distribution of immune cells in the cervicovaginal mucosa remain constant throughout the menstrual cycle of rhesus macaques.

Z Ma1, F X Lü, M Torten, C J Miller.   

Abstract

A number of studies have shown that the ovarian hormone cycle affects genital tract immunoglobulin (Ig) levels and T cell function in both humans and rhesus monkeys. We hypothesized that shifts in immune cell populations occurring in response to hormone cycles are involved in the observed changes in genital tract immunity. To test this hypothesis, we characterized the type, number, and distribution of immune cells in the cervicovaginal mucosa at different stages of the menstrual cycle. Tissues from 18 normal female rhesus macaques were studied by immunohistochemistry and computerized morphometric analysis. The number and distribution of CD1a+ Langerhans' cells, CD2+, CD3+, CD4+, and CD8+ T cells, CD20+ B cells, and surface Ig+ plasma cells did not change in samples collected at the different stages of the cycle. However, in no relation to the stage of the menstrual cycle, the number of Langerhans' cells and other immune cell types was different in the various regions of the cervicovaginal mucosa examined. In addition, variation in thickness of the ectocervical and vaginal epithelium during a normal menstrual cycle of rhesus macaques is not accompanied by changes in intraepithelial immune cell populations. We conclude that steroid hormones do not influence genital mucosal immunity by changing the number or distribution of immune cells in the lower reproductive tract. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11465954     DOI: 10.1006/clim.2001.5058

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  27 in total

1.  The strength of B cell immunity in female rhesus macaques is controlled by CD8+ T cells under the influence of ovarian steroid hormones.

Authors:  F X Lü; K Abel; Z Ma; T Rourke; D Lu; J Torten; M McChesney; C J Miller
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

2.  Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus.

Authors:  Christopher J Miller; Qingsheng Li; Kristina Abel; Eun-Young Kim; Zhong-Min Ma; Stephen Wietgrefe; Lisa La Franco-Scheuch; Lara Compton; Lijie Duan; Marta Dykhuizen Shore; Mary Zupancic; Marc Busch; John Carlis; Steven Wolinsky; Steven Wolinksy; Ashley T Haase
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 3.  Targeting early infection to prevent HIV-1 mucosal transmission.

Authors:  Ashley T Haase
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

4.  Comparison of Follicular and Luteal Phase Mucosal Markers of HIV Susceptibility in Healthy Women.

Authors:  Andrea Ries Thurman; Neelima Chandra; Nazita Yousefieh; Irina Zalenskaya; Thomas Kimble; Susana Asin; Christiane Rollenhagen; Sharon M Anderson; Betsy Herold; Pedro M M Mesquita; Nicola Richardson-Harman; Tina Cunningham; Jill L Schwartz; Gustavo F Doncel
Journal:  AIDS Res Hum Retroviruses       Date:  2016-02-10       Impact factor: 2.205

5.  A long-acting integrase inhibitor protects female macaques from repeated high-dose intravaginal SHIV challenge.

Authors:  Chasity D Andrews; Yun Lan Yueh; William R Spreen; Leslie St Bernard; Mar Boente-Carrera; Kristina Rodriguez; Agegnehu Gettie; Kasi Russell-Lodrigue; James Blanchard; Susan Ford; Hiroshi Mohri; Cecilia Cheng-Mayer; Zhi Hong; David D Ho; Martin Markowitz
Journal:  Sci Transl Med       Date:  2015-01-14       Impact factor: 17.956

6.  The Toll-like receptor 7 (TLR7) agonist, imiquimod, and the TLR9 agonist, CpG ODN, induce antiviral cytokines and chemokines but do not prevent vaginal transmission of simian immunodeficiency virus when applied intravaginally to rhesus macaques.

Authors:  Yichuan Wang; Kristina Abel; Katherine Lantz; Arthur M Krieg; Michael B McChesney; Christopher J Miller
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

Review 7.  Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection.

Authors:  Zdenek Hel; Elizabeth Stringer; Jiri Mestecky
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

8.  Spontaneous cervicovaginal lesions and immune cell infiltrates in nonhuman primates.

Authors:  Carole E Harbison; Mary E Ellis; Susan V Westmoreland
Journal:  Toxicol Pathol       Date:  2013-02-20       Impact factor: 1.902

Review 9.  HIV transmission.

Authors:  George M Shaw; Eric Hunter
Journal:  Cold Spring Harb Perspect Med       Date:  2012-11-01       Impact factor: 6.915

10.  Abrogation of attenuated lentivirus-induced protection in rhesus macaques by administration of depo-provera before intravaginal challenge with simian immunodeficiency virus mac239.

Authors:  Kristina Abel; Tracy Rourke; Ding Lu; Kristen Bost; Michael B McChesney; Christopher J Miller
Journal:  J Infect Dis       Date:  2004-09-24       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.